Efficacy Of An Inpatient Yoga Therapy Program For Cancer Patients

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07776587
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Yoga Therapy (YT) — OTHER
    Yoga Therapy (YT) is an evidence-based mind-body practice recommended for cancer to relieve nausea, fatigue, pain, sleep disruption, psychosocial distress, musculoskeletal symptoms, and cognitive dysfunction, all common symptoms experienced during HSCT.

Study Details

The purpose of this study is to learn whether a yoga therapy program can improve quality of life and reduce symptoms in people undergoing stem cell transplantation compared with an enhanced standard care physical activity program.

Key Dates

First listed
Aug 20, 2026
Start date
Feb 1, 2027
Status verified
Aug 2026
Primary completion
Apr 13, 2030
Completion
Apr 13, 2032

Study Design

Enrollment
300 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: SC: Enhanced Stand of Care Group
    In the experimental \& control interventions: participants will receive up to 3 sessions per week, for a total of up to 10 weeks or 20 sessions, whichever comes first
  • Experimental: YT: Yoga Group
    In the experimental \& control interventions: participants will receive up to 3 sessions per week, for a total of up to 10 weeks or 20 sessions, whichever comes first

Primary Outcome Measure

Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD Anderson Cancer CenterHoustonTexas77030
Lorenzo Cohen, PHD
713-745-4260
Lorenzo Cohen, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

Related Studies